Natural Ingredients and Products Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Gnosis by Lesaffre

United States

Gnosis by Lesaffre Leading Fermentation based multiplatform innovation partner to the pharma, health supplements and functional food players.

Lesaffre, a key global actor in the field of yeast and fermentation, combining Gnosis and Lesaffre Human Care teams into a single unit to offer skills and expertise in microbial fermentation and in the recovery and purification of molecules derived from yeasts and bacteria to offer a unified range of nutritional ingredients to human health customers and partners.

Improving the quality of life of humans and promoting their well-being and health is the specific target of worldwide advanced nutrition. Following the mayor global trend and challenge, Gnosis by Lesaffre offers a wide range of innovative products among its branded functional ingredient merging the excellence in biotech innovation with practical and functional nutraceutical application.

Its mission has been to develop and supply ingredients issued from yeast and bacteria fermentation to the global human care industries. From nutritional and fortified yeasts to yeast fractions, probiotic yeasts and bacteria, vitamin or pure molecules, Gnosis by Lesaffre targets a wide range of applications: digestive health, bone protection, immunity enhancement, joints and liver health, woman’s health, vegetarian support, overall wellbeing and personal care. A complete range of differentiated solutions able to improve and boost human health conditions and compensate for the poor quality of the contemporary diet.

The successful integration of outstanding R&D, strong marketing and sales support and GMP Approved manufacturing facilities enables the company to introduce market-leading products to the worldwide human health industries.

Gnosis by Lesaffre Products Portfolio include:

Quatrefolic®, the InnovACTIVE Folate, is the glucosamine salt of the 5-methyltetrahydrofolate (5-MTHF), the metabolic active form of folate.

VitaMK7® is the optimal vitamin K2 as MK7: a naturally derived, pure, stable all-trans, soy- and solvent-free vitamin K2 in the form of menaquinone-7 (MK7)

Mythocondro® is the first Non-Animal Chondroitin Sulfate produced by a patented fermentation-based manufacturing process. Novel Food EU approved.

Adonat® is the commercially stable form of S-Adenosyl-L-methionine (SAMe), a natural molecule recognized as the most active methyl donor produced in the human body, essential to sustain the normal function of the one carbon metabolism pathway.

Emothion® is the crystalline form of S-Acetyl Glutathione, the cutting-edge alternative developed to overcome the poor effectiveness of GSH supplementation, due to its poor absorption and its hydrolytic degradation in the body.

Biootic® is a probiotic yeast (Saccharomyces boulardii) acting as a temporary flora to protect the intestinal tract and good germs in the intestine.

 

 

 

 

 

Trademarks

  • Quatrefolic
  • Vitamk7
  • Adomet
  • K2&Olive
  • Biooptima
  • Mythocondro
  • Soloesse
  • Phosphocomplex
  • Adogran
  • Adomix
  • Emothion
  • Superesse
  • K2 & Olive
  • Phosphocomplex

Patents

Stable salts of S-Adenosylmethionine and process for the preparation thereof
The present invention refers to new salts of S-adenosylmethionine (SAMe) with improved stability and containing at least 70% by weight of SAMe.
Patent Number: US 8,258,115 | Patent Date: 09/04/2012
Process for the preparation of pharmaceutically acceptable salts of (SS-RS)-S-Adenosyl-L-Methionine
The present invention relates to a process for the preparation of pharmaceutically acceptable salts of (R,S)-S-Adenosyl-L-Methionine and allows to obtain the salified ( R)-(+)-S-Adenosyl-L-Methionine diasteroisomer in amounts lower than or equal to 3% with respect to the salified (S)-(+)-S-Adenosyl-L-Methionine diasteroisomer; the salts that can be obtained by the process of the invention keep their configuration stable in time.
Patent Number: US 6,958,233 | Patent Date: 10/25/2005
Process for the preparation of tablets comprising S-Adenosyl-L-Methionine
The present invention provides a process for the preparation of tablets comprising S-Adenosylmethionine and/or a pharmaceutically and/or dietarily acceptable derivative thereof by blending that active component with specified additives, compressing the blend, followed by coating.
Patent Number: US 7,087,587 | Patent Date: 08/08/2006
A process for the preparation of Vitamin K2
A process for the preparation of vitamin K2 (MK-7) comprising the culture of Bacillus subtilis mutant strain GN13/72DSM 17766 deposited on Dec. 5, 2005 at the DSMZ.
Patent Number: US 7,718,407 | Patent Date: 02/22/2010
Folates, compositions and uses thereof
The present invention relates to folates, compositions and uses thereof; In particular, this invention describes a crystalline or amorphous compound which is a substituted or unsubstituted folate or a reduced folate, or the natural or unnatural isomers thereof, of at least one organic base, as well as compositions and uses thereof. The compounds of the invention show a long lasting stability as well as a peculiarly high watr-solubility.
Patent Number: US 7,947,662 | Patent Date: 05/24/2011
Process for producing glutathione
There is disclosed a fermentation process for producing glutathione which comprises (a) the obtainment of a biomass pre-culture by pre-cultivating, in aerobic conditions, a strain of a glutathione producing yeast where in the glutathione content per biomass unit is higher than 1.2% w/w; (b) the cultivation, in aerobic conditions, of the resulting biomass pre-culture such that the resulting biomass density is higher than 50 g/l; (c) the activation of the cultured biomass; and (d) the recovery of the cultured biomass, extracting glutathione at a pH equal to or lower than 6 and purifying the resulting glutathione. The process allows to obtain glutathione with high yields and relatively low costs.
Patent Number: US 6,902,912 | Patent Date: 06/07/2005
Dried or freeze-dried and/or microencapsulated Saccharomyces cerevisiae cells with a high content of (S)-(+)-S-Adenosyl-L-Methionine, process for their preparation, and compositions containing said ce
Disclosed are dried and/or microencapsulated Saccharomyces cerevisiae cells with a high content of (S)-(+)-S-Adenosyl-L-Methionine, in the form of a free base obtainable from selected high-productivity strains of (S)-(+)-SAMe.
Patent Number: US 9,365,817 | Patent Date: 06/14/2016

GRAS

(6S)-5-methyltetrahydrofolate
Quatrefolic®

BioPharma

Biootic®

VitaMK7®

Mythocondro®

Phosphocomplex®

Feedback